ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,625,378 | -44.8% | 80,600 | -56.3% | 1.60% | -36.4% |
| Q2 2023 | $71,827,239 | -31.3% | 184,300 | -34.3% | 2.51% | -27.7% |
| Q1 2023 | $104,583,206 | -55.8% | 280,700 | -55.1% | 3.47% | -32.3% |
| Q4 2022 | $236,768,750 | +36.4% | 625,000 | +27.1% | 5.13% | +45.3% |
| Q3 2022 | $173,630,000 | -20.0% | 491,800 | -14.1% | 3.53% | -29.1% |
| Q2 2022 | $216,909,000 | +290.9% | 572,500 | +225.3% | 4.98% | +330.8% |
| Q1 2022 | $55,495,000 | +907.5% | 176,000 | +780.0% | 1.16% | +660.5% |
| Q1 2021 | $5,508,000 | – | 20,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |